Clinical Trials Directory

Trials / Terminated

TerminatedNCT00822029

Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Department of Clinical Research and Innovation · Academic / Other
Sex
All
Age
10 Years – 18 Years
Healthy volunteers
Not accepted

Summary

It is a double blind randomized study aiming at estimating the efficiency of oral bisphosphonates on the decrease of osteoporosis by comparing the evolution of densitometric values between two groups of children (treatment versus placebo).

Detailed description

In non walking children with cerebral palsy, osteoporosis is responsible for bone pains and iterative fractures. Classical treatments include physiotherapy, assisted verticalisation by orthesis and correct feeding with vitamin D and calcium supplementation. Yet this isn't always sufficient and isn't always possible. Bisphosphonates, which have been used for years in the treatment of post-menopausic osteoporosis or of osteogenesis imperfecta in children, can turn out to be very useful for non-walking children with cerebral palsy. Studies have been published since 1994 in this indication with encouraging results. Cyclic intravenous administration of bisphosphonates every 3 months showed an objective increase in bone density and a decrease in pains and fractures after one year of treatment. Cyclic intravenous administration nevertheless requires the use of an implanted chamber and iterative hospitalizations. Oral administration should allow to treat these children, who already have many treatments, in a simpler way. The study will concern 40 non-walking children with cerebral palsy aged over 10 years.

Conditions

Interventions

TypeNameDescription
DRUGFOSAMAXpatient receiving one tablet (oral use) 70 mg Fosamax by week
OTHERPLACEBOpatient receiving one tablet (oral use) placebo by week

Timeline

Start date
2009-02-01
Primary completion
2011-02-01
Completion
2011-02-01
First posted
2009-01-14
Last updated
2012-03-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00822029. Inclusion in this directory is not an endorsement.